Logo image of NBHC

NATIONAL BANK HOLD-CL A (NBHC) Stock Fundamental Analysis

NYSE:NBHC - New York Stock Exchange, Inc. - US6337071046 - Common Stock - Currency: USD

38.19  +0.14 (+0.37%)

After market: 38.19 0 (0%)

Fundamental Rating

3

NBHC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 395 industry peers in the Banks industry. NBHC may be in some trouble as it scores bad on both profitability and health. NBHC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

NBHC had positive earnings in the past year.
NBHC had a positive operating cash flow in the past year.
Each year in the past 5 years NBHC has been profitable.
NBHC had a positive operating cash flow in 4 of the past 5 years.
NBHC Yearly Net Income VS EBIT VS OCF VS FCFNBHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

The Return On Assets of NBHC (1.10%) is better than 73.42% of its industry peers.
The Return On Equity of NBHC (8.37%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 1.1%
ROE 8.37%
ROIC N/A
ROA(3y)1.13%
ROA(5y)1.2%
ROE(3y)9.09%
ROE(5y)9.84%
ROIC(3y)N/A
ROIC(5y)N/A
NBHC Yearly ROA, ROE, ROICNBHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 27.33%, NBHC is in the better half of the industry, outperforming 72.15% of the companies in the same industry.
NBHC's Profit Margin has been stable in the last couple of years.
The Operating Margin and Gross Margin are not available for NBHC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 27.33%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-2.49%
PM growth 5Y0.93%
GM growth 3YN/A
GM growth 5YN/A
NBHC Yearly Profit, Operating, Gross MarginsNBHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

NBHC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NBHC has been increased compared to 1 year ago.
The number of shares outstanding for NBHC has been increased compared to 5 years ago.
NBHC has a worse debt/assets ratio than last year.
NBHC Yearly Shares OutstandingNBHC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
NBHC Yearly Total Debt VS Total AssetsNBHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

The Debt to FCF ratio of NBHC is 0.60, which is an excellent value as it means it would take NBHC, only 0.60 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.60, NBHC belongs to the top of the industry, outperforming 80.76% of the companies in the same industry.
A Debt/Equity ratio of 0.06 indicates that NBHC is not too dependend on debt financing.
The Debt to Equity ratio of NBHC (0.06) is better than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.6
Altman-Z N/A
ROIC/WACCN/A
WACC16.64%
NBHC Yearly LT Debt VS Equity VS FCFNBHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
NBHC Yearly Current Assets VS Current LiabilitesNBHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

NBHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.93%.
NBHC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.78% yearly.
The Revenue has decreased by -2.66% in the past year.
NBHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.10% yearly.
EPS 1Y (TTM)-12.93%
EPS 3Y2.5%
EPS 5Y4.78%
EPS Q2Q%-23.17%
Revenue 1Y (TTM)-2.66%
Revenue growth 3Y10.98%
Revenue growth 5Y7.1%
Sales Q2Q%-1.3%

3.2 Future

Based on estimates for the next years, NBHC will show a small growth in Earnings Per Share. The EPS will grow by 4.78% on average per year.
Based on estimates for the next years, NBHC will show a small growth in Revenue. The Revenue will grow by 5.77% on average per year.
EPS Next Y1.63%
EPS Next 2Y4.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.78%
Revenue Next 2Y5.77%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
NBHC Yearly Revenue VS EstimatesNBHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
NBHC Yearly EPS VS EstimatesNBHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

3

4. Valuation

4.1 Price/Earnings Ratio

NBHC is valuated correctly with a Price/Earnings ratio of 12.60.
The rest of the industry has a similar Price/Earnings ratio as NBHC.
NBHC is valuated rather cheaply when we compare the Price/Earnings ratio to 24.95, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 10.80, the valuation of NBHC can be described as very reasonable.
The rest of the industry has a similar Price/Forward Earnings ratio as NBHC.
NBHC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.6
Fwd PE 10.8
NBHC Price Earnings VS Forward Price EarningsNBHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

NBHC's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 11.58
EV/EBITDA N/A
NBHC Per share dataNBHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NBHC does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)7.75
PEG (5Y)2.64
EPS Next 2Y4.78%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.23%, NBHC has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.42, NBHC has a dividend in line with its industry peers.
NBHC's Dividend Yield is a higher than the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 3.23%

5.2 History

The dividend of NBHC is nicely growing with an annual growth rate of 8.36%!
NBHC has been paying a dividend for at least 10 years, so it has a reliable track record.
NBHC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.36%
Div Incr Years9
Div Non Decr Years12
NBHC Yearly Dividends per shareNBHC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

39.49% of the earnings are spent on dividend by NBHC. This is a low number and sustainable payout ratio.
NBHC's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP39.49%
EPS Next 2Y4.78%
EPS Next 3YN/A
NBHC Yearly Income VS Free CF VS DividendNBHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M
NBHC Dividend Payout.NBHC Dividend Payout, showing the Payout Ratio.NBHC Dividend Payout.PayoutRetained Earnings

NATIONAL BANK HOLD-CL A

NYSE:NBHC (5/13/2025, 8:04:00 PM)

After market: 38.19 0 (0%)

38.19

+0.14 (+0.37%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-22 2025-04-22/amc
Earnings (Next)07-21 2025-07-21/amc
Inst Owners100.27%
Inst Owner Change0.03%
Ins Owners2.26%
Ins Owner Change2.72%
Market Cap1.45B
Analysts74.55
Price Target41.41 (8.43%)
Short Float %2.01%
Short Ratio2.48
Dividend
Industry RankSector Rank
Dividend Yield 3.23%
Yearly Dividend1.13
Dividend Growth(5Y)8.36%
DP39.49%
Div Incr Years9
Div Non Decr Years12
Ex-Date05-30 2025-05-30 (0.3)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.63%
Min EPS beat(2)-18.19%
Max EPS beat(2)10.94%
EPS beat(4)2
Avg EPS beat(4)-1.06%
Min EPS beat(4)-18.19%
Max EPS beat(4)13.02%
EPS beat(8)5
Avg EPS beat(8)0.3%
EPS beat(12)9
Avg EPS beat(12)4.35%
EPS beat(16)12
Avg EPS beat(16)4.68%
Revenue beat(2)1
Avg Revenue beat(2)-3.23%
Min Revenue beat(2)-6.88%
Max Revenue beat(2)0.42%
Revenue beat(4)2
Avg Revenue beat(4)-2.7%
Min Revenue beat(4)-6.88%
Max Revenue beat(4)1.1%
Revenue beat(8)3
Avg Revenue beat(8)-2.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.48%
Revenue beat(16)6
Avg Revenue beat(16)-1.86%
PT rev (1m)-15.77%
PT rev (3m)-17.14%
EPS NQ rev (1m)1.91%
EPS NQ rev (3m)1.91%
EPS NY rev (1m)-0.25%
EPS NY rev (3m)-1.11%
Revenue NQ rev (1m)-0.8%
Revenue NQ rev (3m)-1.13%
Revenue NY rev (1m)-1.78%
Revenue NY rev (3m)-2.09%
Valuation
Industry RankSector Rank
PE 12.6
Fwd PE 10.8
P/S 3.57
P/FCF 11.58
P/OCF 8.82
P/B 1.09
P/tB 1.5
EV/EBITDA N/A
EPS(TTM)3.03
EY7.93%
EPS(NY)3.54
Fwd EY9.26%
FCF(TTM)3.3
FCFY8.64%
OCF(TTM)4.33
OCFY11.34%
SpS10.68
BVpS34.9
TBVpS25.43
PEG (NY)7.75
PEG (5Y)2.64
Profitability
Industry RankSector Rank
ROA 1.1%
ROE 8.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 27.33%
GM N/A
FCFM 30.88%
ROA(3y)1.13%
ROA(5y)1.2%
ROE(3y)9.09%
ROE(5y)9.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-2.49%
PM growth 5Y0.93%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.6
Debt/EBITDA N/A
Cap/Depr 160.32%
Cap/Sales 9.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 113%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC16.64%
ROIC/WACCN/A
Cap/Depr(3y)124.34%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.96%
Cap/Sales(5y)N/A
Profit Quality(3y)159.33%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.93%
EPS 3Y2.5%
EPS 5Y4.78%
EPS Q2Q%-23.17%
EPS Next Y1.63%
EPS Next 2Y4.78%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.66%
Revenue growth 3Y10.98%
Revenue growth 5Y7.1%
Sales Q2Q%-1.3%
Revenue Next Year4.78%
Revenue Next 2Y5.77%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1.75%
FCF growth 3Y-12.4%
FCF growth 5Y29.61%
OCF growth 1Y12.2%
OCF growth 3Y-4.72%
OCF growth 5Y28.57%